iPS Cells of Patients for Models of Retinal Dystrophies
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Retinal Dystrophies
- Sponsor
- University Hospital, Montpellier
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- number of human cell models obtained
- Status
- Completed
- Last Updated
- 9 months ago
Overview
Brief Summary
The investigators are focused on inherited retinal dystrophies with an aim to further understand disease pathophysiology and to elaborate novel treatments, as, to date, there is no effective treatment to prevent blindness.
The main goal of this study is to generate human cellular models of healthy and disease retinas and perform studies to evaluate the efficiency of gene therapy approaches for different diseases.
Skin biopsies of volunteers are cultured to isolate fibroblasts that are then reprogrammed into iPS cells. Healthy and disease-specific iPS cells are then differentiated into retinal models.
This study should help to elucidate disease pathways and to provide proof-of-concept for various therapeutic approaches.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
number of human cell models obtained
Time Frame: 10 years